Iopamiro (Iopamidol)

Iopamidol contains iodine atoms that have a high atomic number, which absorb X‑rays. When injected, it distributes in the vascular and extracellular compartments, increasing X‑ray attenuation and creating a clear contrast between the enhanced structures and surrounding tissues.

The dose of Iopamiro is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and the required level of contrast enhancement. The healthcare professional selects the appropriate volume and concentration for each procedure.

Safety of iopamidol in pregnancy and lactation has not been fully established. It should only be used when clearly needed and after a careful risk‑benefit assessment by the clinician. Breastfeeding mothers should discuss any precautions with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, providing the required quantity and institutional details. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then replies with pricing, availability, shipping terms and any necessary import documentation.

Iopamiro (iopamidol) is a non‑ionic, low‑osmolality contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image quality to other non‑ionic agents such as iohexol, while reducing the incidence of discomfort and adverse reactions.

Iopamiro should be stored at controlled room temperature, below 25 °C, in its original container. Protect the solution from light and moisture, and avoid freezing. Inspect the vial for particulate matter before use and discard if any is present.

Iopamiro is supplied as a sterile solution for injection and is administered intravenously, intra‑arterially, intra‑articularly, or intrathecally by a qualified healthcare professional, following the protocol of the specific imaging procedure and using aseptic technique.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, acute kidney injury, hypotension, seizures, and cardiopulmonary arrest. Prompt recognition and appropriate emergency management are essential if these events occur.

Iopamiro is contraindicated in patients with a known hypersensitivity to iopamidol or other iodinated contrast agents, those with severe renal impairment, uncontrolled hyperthyroidism, or a history of severe adverse reactions to contrast media. Clinicians should evaluate each patient before administration.